Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-02-23 @ 8:31 PM
Study NCT ID:
NCT00087958
Status:
COMPLETED
Last Update Posted:
2009-05-01
First Post:
2004-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EFC6088
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
ICD Study Director
Old Organization:
sanofi-aventis